Close

Lipocine (LPCN) Prevails in LPCN 1021 Patent Suit

October 7, 2016 2:34 PM EDT Send to a Friend
Lipocine Inc. (Nasdaq: LPCN) announced that U.S. District Court in Delaware granted our motion to dismiss a lawsuit filed by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login